About this trial
The goal of this observational study is to learn more about how genes impact the risk of kidney disease. Anyone 18 or older living in the US is eligible, and a diagnosis of kidney disease is NOT required. Study participation is online, and it takes about 20 minutes to complete health surveys and request a saliva collection kit sent through US mail. In return, study participants may opt to receive information about their genetic ancestry at no cost.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
age 18 years or older
currently living in the United States
able to understand and follow written instructions in English
have access to the internet and a computer, laptop, tablet or smart phone
Disqualifiers
Not able to meet or fulfill any of the inclusion criter
Trial population
The study population consists of anyone at least 18 years old who lives in the United States, including both individuals who have or had kidney disease and those who have not. Participants include males, females, non-binary, and all race-ethnic groups.
Trial design
Case-control
Cross-sectional
Treatments tested in this trial
Saliva sample
GeneticSaliva sample is sent via prepaid US Mail for DNA extraction
Health surveys
Other interventionHealth surveys are filled out online in the study portal.
Treatment groups
Trial outcomes
Primary outcomes
Genetic risk variants associated with kidney disease
Genetic factors will be measured through whole exome sequencing along with genotyping of common variants, and then correlated with kidney disease and/or kidney disease subtype.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Rutgers, The State University of New Jersey
Lead sponsor
Regeneron Pharmaceuticals
Collaborator